Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Universita di Verona
Age
6–14
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnostic criteria: the classification of asthma will be based on clinical history and examination and pulmonary function parameters, according to international guidelines.
Stage and/or severity of condition: atopic children with mild intermittent asthma will be enrolled. Atopy will be evaluated by skin-prick test to common allergens in the area.
Confirmatory physical and laboratory findings:
Age: ranging in age 6 to 14 years.
Evidence of susceptibility to the disease under study
Patients have not used ICS during 3-month period prior to study entry
You may not be if
Patients will be excluded if they had used oral steroids in the last month.
Patients will be excluded if they had acute or chronic lung diseases other than asthma, upper or lower airway infection in the previous 3 weeks or during the trial, acute asthma exacerbation, or had used oral steroids in the last month.
Patients will be excluded if they had acute or chronic lung diseases other than asthma, upper or lower airway infections in the previous 3 weeks or during the trial, acute asthma exacerbation, or had used oral steroids in the last month.
Clareo Health | Effect of Montelukast on Remodelling Markers in Asthmatic Children
